Eupraxia Pharmaceuticals (TSE:EPRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Eupraxia Pharmaceuticals has successfully raised C$44.5 million through a non-brokered private placement of preferred shares to support its clinical trials and other corporate initiatives. Additionally, the company strengthened its board with the appointment of Joseph Freedman, a seasoned private equity investor.
For further insights into TSE:EPRX stock, check out TipRanks’ Stock Analysis page.